Empowered Patient Podcast

Rick Focke, Director of Product and Market Development for Johnson Controls, focuses on AI's role in modernizing healthcare security and helping hospitals shift from reactive to proactive security. AI is improving staff efficiency, reducing nuisance alarms, detecting unauthorized wandering, and transforming cameras into multifaceted sensors for tasks such as fall detection and asset tracking, all without constant human monitoring. Of particular concern is the rise in workplace violence, and these cameras can detect aggressive behavior before incidents escalate.

Rick explains, "Hospitals are a unique use case where they are in a very public space. So how do you secure a public space? You have to really weigh the security versus public areas and then keep the really sensitive areas safe and secure. And even though it might be mainly public spaces, keep a vigilant watch on those spaces. And we're using now a lot of AI to help in that task to really react quickly, to be proactive when things do go awry."

"The most unmet needs, I would say, would be being more proactive in the workplace violence area. It is really increasing from all the studies I've been reading. We need to do a better job of heading off in the pass. And that's where AI is really helping. With AI, you can train the system to detect bad behaviors or aggressive behaviors in patients, contractors, or anyone. When that happens, the system can alert the operators. They can send out different kinds of alerts based on how important it is, which really helps create a safer environment. We also have a lot of wearables that have person-down alerts when something happens that can reinforce that whole response when something is going awry."

#JohnsonContols #HealthcareSecurity #HospitalSafety #AIinHealthcare #ClinicalSafety #WorkplaceViolencePrevention #PPECompliance #InfectionControl #SmartHospital #DigitalHealth #HealthIT #PatientSafety #HealthcareInnovation #OperationalExcellence

johnsoncontrols.com

Listen to the podcast here

Rick Focke, Director of Product and Market Development for Johnson Controls, focuses on AI's role in modernizing healthcare security and helping hospitals shift from reactive to proactive security. AI is improving staff efficiency, reducing nuisance alarms, detecting unauthorized wandering, and transforming cameras into multifaceted sensors for tasks such as fall detection and asset tracking, all without constant human monitoring. Of particular concern is the rise in workplace violence, and these cameras can detect aggressive behavior before incidents escalate.

Rick explains, "Hospitals are a unique use case where they are in a very public space. So how do you secure a public space? You have to really weigh the security versus public areas and then keep the really sensitive areas safe and secure. And even though it might be mainly public spaces, keep a vigilant watch on those spaces. And we're using now a lot of AI to help in that task to really react quickly, to be proactive when things do go awry."

"The most unmet needs, I would say, would be being more proactive in the workplace violence area. It is really increasing from all the studies I've been reading. We need to do a better job of heading off in the pass. And that's where AI is really helping. With AI, you can train the system to detect bad behaviors or aggressive behaviors in patients, contractors, or anyone. When that happens, the system can alert the operators. They can send out different kinds of alerts based on how important it is, which really helps create a safer environment. We also have a lot of wearables that have person-down alerts when something happens that can reinforce that whole response when something is going awry."

#JohnsonContols #HealthcareSecurity #HospitalSafety #AIinHealthcare #ClinicalSafety #WorkplaceViolencePrevention #PPECompliance #InfectionControl #SmartHospital #DigitalHealth #HealthIT #PatientSafety #HealthcareInnovation #OperationalExcellence

johnsoncontrols.com

Download the transcript here

Dr. Yana Aznavour, CEO and Founder of Endometrics, discusses the significant diagnostic delay women face with endometriosis due to non-specific symptoms and the current reliance on invasive surgery for a definitive diagnosis. The company has developed a non-invasive at-home diagnostic test that uses menstrual blood to analyze a five-gene biomarker signature with high accuracy. This objective, molecular-based test shortens the time to the correct treatment and changes the dynamic of the patient-doctor conversation.

Yana explains, "We are developing non-invasive diagnostic tests, and we are primarily addressing the huge diagnostic delay that our patients, women, face, unfortunately. This happens because there are tons of non-specific symptoms and inconclusive imaging findings, and women face unnecessary appointments and procedures before reaching the point of definitive diagnosis. We are working rigorously towards bringing non-invasive, highly reliable diagnostic tests to help women get clarity and answers behind their symptoms way earlier in the journey."

"Menstrual pain and pain in general that women try to express and define at physician's appointments, it's being dismissed because they try to explain that, but in many cases, they cannot find exactly where it hurts, especially in endometriosis. Due to this, unfortunately, at the primary care level and the non-OB/GYN level, they're being dismissed and repeatedly misdiagnosed for years. The key reason is the non-specific symptoms because symptoms like pelvic pain and pain with urination overlap with the list of diagnoses. Currently, the definitive diagnosis for endometriosis is achieved through surgery. Nobody would do surgery after the first appointment. So, endometriosis becomes a diagnosis of exclusion, unfortunately, and it takes years before patients receive the final diagnosis."

#Endometrics #Endometriosis, #WomensHealth, #Biomarkers, #Diagnostics, #FemTech #Gynecology #PrecisionMedicine

endometrics.us

Listen to the podcast here

Dr. Yana Aznavour, CEO and Founder of Endometrics, discusses the significant diagnostic delay women face with endometriosis due to non-specific symptoms and the current reliance on invasive surgery for a definitive diagnosis. The company has developed a non-invasive at-home diagnostic test that uses menstrual blood to analyze a five-gene biomarker signature with high accuracy. This objective, molecular-based test shortens the time to the correct treatment and changes the dynamic of the patient-doctor conversation.

Yana explains, "We are developing non-invasive diagnostic tests, and we are primarily addressing the huge diagnostic delay that our patients, women, face, unfortunately. This happens because there are tons of non-specific symptoms and inconclusive imaging findings, and women face unnecessary appointments and procedures before reaching the point of definitive diagnosis. We are working rigorously towards bringing non-invasive, highly reliable diagnostic tests to help women get clarity and answers behind their symptoms way earlier in the journey."

"Menstrual pain and pain in general that women try to express and define at physician's appointments, it's being dismissed because they try to explain that, but in many cases, they cannot find exactly where it hurts, especially in endometriosis. Due to this, unfortunately, at the primary care level and the non-OB/GYN level, they're being dismissed and repeatedly misdiagnosed for years. The key reason is the non-specific symptoms because symptoms like pelvic pain and pain with urination overlap with the list of diagnoses. Currently, the definitive diagnosis for endometriosis is achieved through surgery. Nobody would do surgery after the first appointment. So, endometriosis becomes a diagnosis of exclusion, unfortunately, and it takes years before patients receive the final diagnosis."

#Endometrics #Endometriosis, #WomensHealth, #Biomarkers, #Diagnostics, #FemTech #Gynecology #PrecisionMedicine

endometrics.us

Download the transcript here

Thomas Ruggia, CEO and President of Theialife, delves into pediatric progressive myopia, a severe form of nearsightedness caused by the elongation of the eye in children, which can lead to significant long-term health issues. The development of their novel oral therapy is designed to address the underlying physiology of the eye by strengthening the sclera to halt its elongation, unlike other treatments that only manage visual acuity. This oral therapy is available in capsules that can be opened and sprinkled on food, making it patient-friendly and child-compliant, avoiding the need for often hard-to-administer eye drops.

Thomas explains, "Myopia is known as nearsightedness, and I think everybody is familiar with folks who wear spectacles for nearsightedness, or contact lenses, or have had LASIK surgery. But pediatric progressive myopia is a subset of myopia that is particularly difficult."

"The pediatric progressive myopia is a disease that's a bit different than just standard nearsightedness. Someone who might be minus two myopic can easily correct their vision with glasses. In this type of condition, generally, parents have a child who is having some difficulty seeing, and the next year, the child has extreme difficulty seeing. And then every year following, things get worse and worse. They end up at the optometrist or ophthalmologist for extensive recalculating their prescription, new glasses for those years of maybe between six and 16 years old."

"We're actually talking about a disorder that continues for the life of the patient that leads to significant challenges between the ages of, let's say, 40 and 80, where this elongated eye, which is what the condition really is, leads to challenges in retina detachment, maculopathy, early cataracts, and other conditions that are unique to the myopia patients."

"So we have a number of medical devices and pharmaceutical interventions that are being studied today, all of which have an effect on the visual acuity a patient might experience, but none of them affect the underlying structural changes in the eye during that time period. And our ND10 from Theialife has the potential to do so."

#Theialife #MyopiaAwareness #PediatricMyopia #PediatricOphthalmology #VisionHealth #ND10 #AdenosineReceptors #7Methylxanthine #MyopiaManagement #Ophthalmology #Optometry #ChildEyeHealth #ScleralStrengthening #OphthalmicInnovation #EyeCare

Theialife.com

Listen to the podcast here

Thomas Ruggia, CEO and President of Theialife, delves into pediatric progressive myopia, a severe form of nearsightedness caused by the elongation of the eye in children, which can lead to significant long-term health issues. The development of their novel oral therapy is designed to address the underlying physiology of the eye by strengthening the sclera to halt its elongation, unlike other treatments that only manage visual acuity. This oral therapy is available in capsules that can be opened and sprinkled on food, making it patient-friendly and child-compliant, avoiding the need for often hard-to-administer eye drops.

Thomas explains, "Myopia is known as nearsightedness, and I think everybody is familiar with folks who wear spectacles for nearsightedness, or contact lenses, or have had LASIK surgery. But pediatric progressive myopia is a subset of myopia that is particularly difficult."

"The pediatric progressive myopia is a disease that's a bit different than just standard nearsightedness. Someone who might be minus two myopic can easily correct their vision with glasses. In this type of condition, generally, parents have a child who is having some difficulty seeing, and the next year, the child has extreme difficulty seeing. And then every year following, things get worse and worse. They end up at the optometrist or ophthalmologist for extensive recalculating their prescription, new glasses for those years of maybe between six and 16 years old."

"We're actually talking about a disorder that continues for the life of the patient that leads to significant challenges between the ages of, let's say, 40 and 80, where this elongated eye, which is what the condition really is, leads to challenges in retina detachment, maculopathy, early cataracts, and other conditions that are unique to the myopia patients."

"So we have a number of medical devices and pharmaceutical interventions that are being studied today, all of which have an effect on the visual acuity a patient might experience, but none of them affect the underlying structural changes in the eye during that time period. And our ND10 from Theialife has the potential to do so."

#Theialife #MyopiaAwareness #PediatricMyopia #PediatricOphthalmology #VisionHealth #ND10 #AdenosineReceptors #7Methylxanthine #MyopiaManagement #Ophthalmology #Optometry #ChildEyeHealth #ScleralStrengthening #OphthalmicInnovation #EyeCare

Theialife.com

Download the transcript here

Stephanie Broussard, Director of Social Work at Thyme Care, describes a model of interdisciplinary social support for cancer patients to increase access to medical services and address social, emotional, and financial challenges. Integrated services target family dynamics, social determinants of health, and building trust to drive better patient outcomes. As cancer increasingly becomes a chronic condition, there is a growing need to support the management of long-term physical and emotional effects and use technology to increase efficiency and support the Thyme Care human-focused approach.

Stephanie explains, "Thyme Care is really designed to try to integrate and increase access for those navigating cancers. So we believe that in order to serve people really well, you don't take things away, you actually add things. If we can increase access and increase the ability for patients to navigate the health system, then we're able to better navigate their utilization. So we try to increase access through access to an interdisciplinary team. We have nurse practitioners, nurses, even oncologists and primary care physicians on our team, social workers, and lay people who help us make sure that patients can get what they need at the right time. And so it's really about giving patients access to the right services at the right time to improve their outcomes."

"We think about how their cancer impacts every facet of their life. And so, we often talk a lot about the financial toxicity of cancer, but social issues that were affecting folks don't just stop because cancer happened. Oftentimes, it even exacerbates those things. So think about family dynamics, think about social determinants of health, like the cost of medications and access, but also all the other things that can be impacted by cancer."

#ThymeCare #ValueBasedCare #SocialWorkMonth #OncologySocialWork #MentalHealthMatters #CaregiverSupport #PatientExperience #HealthEquity #OncologyCare #ValueBasedCare #CareCoordination #SocialDeterminantsOfHealth #SDoH #CancerSurvivorship #Caregivers #NurseNavigation #PalliativeCare

thymecare.com

Listen to the podcast here

Stephanie Broussard, Director of Social Work at Thyme Care, describes a model of interdisciplinary social support for cancer patients to increase access to medical services and address social, emotional, and financial challenges. Integrated services target family dynamics, social determinants of health, and building trust to drive better patient outcomes. As cancer increasingly becomes a chronic condition, there is a growing need to support the management of long-term physical and emotional effects and use technology to increase efficiency and support the Thyme Care human-focused approach.

Stephanie explains, "Thyme Care is really designed to try to integrate and increase access for those navigating cancers. So we believe that in order to serve people really well, you don't take things away, you actually add things. If we can increase access and increase the ability for patients to navigate the health system, then we're able to better navigate their utilization. So we try to increase access through access to an interdisciplinary team. We have nurse practitioners, nurses, even oncologists and primary care physicians on our team, social workers, and lay people who help us make sure that patients can get what they need at the right time. And so it's really about giving patients access to the right services at the right time to improve their outcomes."

"We think about how their cancer impacts every facet of their life. And so, we often talk a lot about the financial toxicity of cancer, but social issues that were affecting folks don't just stop because cancer happened. Oftentimes, it even exacerbates those things. So think about family dynamics, think about social determinants of health, like the cost of medications and access, but also all the other things that can be impacted by cancer."

#ThymeCare #ValueBasedCare #SocialWorkMonth #OncologySocialWork #MentalHealthMatters #CaregiverSupport #PatientExperience #HealthEquity #OncologyCare #ValueBasedCare #CareCoordination #SocialDeterminantsOfHealth #SDoH #CancerSurvivorship #Caregivers #NurseNavigation #PalliativeCare

thymecare.com

Download the transcript here

Dr. Stephanie Lahr, Chief Medical Officer at uPerform, highlights the critical need for new ways to conduct health IT education. Traditional one-time training sessions for large groups are no longer sufficient for the constantly evolving healthcare technologies. Self-paced and personalized training is the way to meet users at their individual skill levels, freeing up training teams to provide targeted support and build organizational competencies, including how to effectively use AI.

Stephanie explains, "This idea, which we are seeing evolve rapidly, is that as we integrate technology into healthcare delivery, people need to understand how to use it, which requires ongoing training, support, and communication."

"It's really a way to think about doing just-in-time, as-needed, self-driven education based on the user for whatever needs might arise with the technology they're using in care delivery. Often, that starts with systems like the EHR and ERP, but it goes far beyond that. And we're seeing that more and more as different kinds of technologies find their way into healthcare delivery to support the care providers in what they're trying to do."

"Traditionally, we had this idea that we rolled out technology, and you did some training, which usually involved a classroom, a quick video tutorial, or maybe an online course or something along those lines. And it was sort of a one-and-done: you learned it, you went, you moved on, and you used it. And I think what we're now seeing is that the systems themselves are changing constantly."

#uPerform #AI #JustInTimeTraining #WorkflowEducation #HealthIT #EHR #ClinicalInformatics #DigitalHealth #ClinicianExperience #HealthcareInnovation #MedicalEducation #AIinHealthcare

uperform.com

Listen to the podcast here

Dr. Stephanie Lahr, Chief Medical Officer at uPerform, highlights the critical need for new ways to conduct health IT education. Traditional one-time training sessions for large groups are no longer sufficient for the constantly evolving healthcare technologies. Self-paced and personalized training is the way to meet users at their individual skill levels, freeing up training teams to provide targeted support and build organizational competencies, including how to effectively use AI.

Stephanie explains, "This idea, which we are seeing evolve rapidly, is that as we integrate technology into healthcare delivery, people need to understand how to use it, which requires ongoing training, support, and communication."

"It's really a way to think about doing just-in-time, as-needed, self-driven education based on the user for whatever needs might arise with the technology they're using in care delivery. Often, that starts with systems like the EHR and ERP, but it goes far beyond that. And we're seeing that more and more as different kinds of technologies find their way into healthcare delivery to support the care providers in what they're trying to do."

"Traditionally, we had this idea that we rolled out technology, and you did some training, which usually involved a classroom, a quick video tutorial, or maybe an online course or something along those lines. And it was sort of a one-and-done: you learned it, you went, you moved on, and you used it. And I think what we're now seeing is that the systems themselves are changing constantly."

#uPerform #AI #JustInTimeTraining #WorkflowEducation #HealthIT #EHR #ClinicalInformatics #DigitalHealth #ClinicianExperience #HealthcareInnovation #MedicalEducation #AIinHealthcare

uperform.com

Download the transcript here